XBIT
XBiotech Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.00
−5.66%Latest reported
- Last report date
- Aug 13, 2026
- EPS actual
- -$0.22
- EPS estimate
- $0.03
- Revenue actual
- —
- Revenue estimate
- $7.0M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 0
- EPS misses (12Q)
- 2
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -766.7%
- Revenue beats (12Q)
- 0
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 13, 2026 | $0.03 | -$0.22 | Miss -833.33% | — |
| May 14, 2026 | $0.03 | -$0.18 | Miss -700.00% | — |
| Mar 13, 2026 | — | -$0.88 | — | — |
| Nov 12, 2025 | — | -$0.20 | — | — |
| Aug 13, 2025 | — | -$0.06 | — | — |
| May 14, 2025 | — | -$0.36 | — | — |
| Mar 18, 2025 | — | -$0.34 | — | — |
| Nov 13, 2024 | — | -$0.16 | — | — |
| May 10, 2024 | — | -$0.33 | — | — |
| Mar 15, 2024 | — | -$0.16 | — | $2.6M |
| Nov 9, 2023 | — | -$0.24 | — | — |
| Aug 11, 2023 | — | -$0.29 | — | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Aug 13, 2026